| | Identification | Back Directory |  | [Name] 
 3,3-BIS(P-HYDROXYPHENYL)OXINDOLE
 |  | [CAS] 
 125-13-3
 |  | [Synonyms] 
 isolax
 lavema
 recolon
 neodrast
 normalax
 hoscolax
 propellax
 veripaque
 phenolisatin
 OXYPHENISATIN
 diphenolisatin
 oxyphenisatine
 isatinbisphenol
 TIMTEC-BB SBB008302
 4,4’-dihydroxydiphenylisatin
 3,3-BIS(4-HYDROXPHENYL)OXINDOLE
 3,3-BIS(P-HYDROXYPHENYL)OXINDOLE
 3,3-BIS(4-HYDROXYPHENYL)OXINDOLE
 3,3-bis(p-hydroxyphenyl)-2-indolinon
 3,3-bis(p-hydroxyphenyl)-2-indolinone
 3,3-bis(4-hydroxyphenyl)indolin-2-one
 3,3-BIS(4-HYDROXYPHENYL)-2-INDOLINONE
 3,3-Bis(4-hydroxyphenyl)indoline-2-one
 3,3-bis(4-hydroxyphenyl)-1H-indol-2-one
 3,3-Bis(4-Hydroxsyphenyl)-2(3H)-Indolone
 3,3-BIS(P-HYDROXYPHENYL)OXINDOLE USP/EP/BP
 1,3-dihydro-3,3-bis(4-hydroxyphenyl)-2h-indol-2-on
 1,3-dihydro-3,3-bis(4-hydroxyphenyl)-2h-indol-2-one
 3,3-Bis(4-hydroxyphenyl)-1,3-dihydro-2H-indol-2-one
 2H-Indol-2-one, 1,3-dihydro-3,3-bis(4-hydroxyphenyl)-
 |  | [EINECS(EC#)] 
 204-728-1
 |  | [Molecular Formula] 
 C20H15NO3
 |  | [MDL Number] 
 MFCD00022794
 |  | [MOL File] 
 125-13-3.mol
 |  | [Molecular Weight] 
 317.34
 | 
 | Chemical Properties | Back Directory |  | [Melting point ] 
 260-261 °C
 |  | [Boiling point ] 
 562.9±50.0 °C(Predicted)
 |  | [density ] 
 1.352±0.06 g/cm3(Predicted)
 |  | [storage temp. ] 
 Store at -20°C
 |  | [solubility ] 
 DMSO : ≥ 28 mg/mL (88.23 mM)
 |  | [form ] 
 Solid
 |  | [pka] 
 9.42±0.30(Predicted)
 |  | [color ] 
 White to off-white
 | 
 | Hazard Information | Back Directory |  | [Chemical Properties] 
 Crystallization. Melting point>260℃.
 |  | [Uses] 
 Oxyphenisatine is a diphenolic laxative and it’s prodrug Oxyphenisatine acetate inhibits the growth of the breast cancer cell lines MCF7, T47D, HS578T, and MDA-MB-468 by inducing multifaceted cell starvation response, which ultimately induces programmed cell death.
 |  | [Definition] 
 ChEBI: Oxyphenisatine is a member of indoles.
 |  | [in vivo] 
 
 Toxicity studies demonstrate that mice tolerate IP administration of OXY at 300 mg/kg once daily or 200 mg/kg twice daily. Administration of OXY at 300 mg/kg IP once daily for 10 days results in significantly smaller tumors from day 33 to day 52[1]. | 
 |  |